These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 2822140)
1. Effect of ketoconazole on metabolism and binding of 1,25-dihydroxyvitamin D-3 by intact rat osteogenic sarcoma cells. Pols HA; Schilte HP; Visser TJ; Birkenhager JC Biochim Biophys Acta; 1987 Nov; 931(2):115-9. PubMed ID: 2822140 [TBL] [Abstract][Full Text] [Related]
2. Evidence that the self-induced metabolism of 1,25-dihydroxyvitamin D-3 limits the homologous up-regulation of its receptor in rat osteosarcoma cells. Pols HA; Birkenhäger JC; Schilte JP; Visser TJ Biochim Biophys Acta; 1988 Jun; 970(2):122-9. PubMed ID: 2838094 [TBL] [Abstract][Full Text] [Related]
3. Retinoic acid stimulates 1,25-dihydroxyvitamin D3 binding in rat osteosarcoma cells. Petkovich PM; Heersche JN; Tinker DO; Jones G J Biol Chem; 1984 Jul; 259(13):8274-80. PubMed ID: 6330107 [TBL] [Abstract][Full Text] [Related]
4. Binding and metabolism of 1,25-dihydroxyvitamin D3 in cultured bovine parathyroid cells. Brown AJ; Berkoben M; Ritter CS; Slatopolsky E Endocrinology; 1992 Jan; 130(1):276-81. PubMed ID: 1309332 [TBL] [Abstract][Full Text] [Related]
5. The effects of MC903 on 1,25-(OH)2D3 receptor binding, 24-hydroxylase activity and in vitro bone resorption. Pols HA; Birkenhäger JC; Schilte JP; Bos MP; van Leeuwen JP Bone Miner; 1991 Aug; 14(2):103-11. PubMed ID: 1655130 [TBL] [Abstract][Full Text] [Related]
6. Ketoconazole inhibits self-induced metabolism of 1,25-dihydroxyvitamin D3 and amplifies 1,25-dihydroxyvitamin D3 receptor up-regulation in rat osteosarcoma cells. Reinhardt TA; Horst RL Arch Biochem Biophys; 1989 Aug; 272(2):459-65. PubMed ID: 2546501 [TBL] [Abstract][Full Text] [Related]
7. Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor. Dokoh S; Donaldson CA; Haussler MR Cancer Res; 1984 May; 44(5):2103-9. PubMed ID: 6324995 [TBL] [Abstract][Full Text] [Related]
8. Heterologous up-regulation of the 1,25-dihydroxyvitamin D3 receptor by parathyroid hormone (PTH) and PTH-like peptide in osteoblast-like cells. Pols HA; van Leeuwen JP; Schilte JP; Visser TJ; Birkenhäger JC Biochem Biophys Res Commun; 1988 Oct; 156(1):588-94. PubMed ID: 2845985 [TBL] [Abstract][Full Text] [Related]
10. Evidence that estrogens modulate activity and increase the number of 1,25-dihydroxyvitamin D receptors in osteoblast-like cells (ROS 17/2.8). Liel Y; Kraus S; Levy J; Shany S Endocrinology; 1992 May; 130(5):2597-601. PubMed ID: 1315250 [TBL] [Abstract][Full Text] [Related]
11. Ligand-dependent regulation of the 1,25-dihydroxyvitamin D3 receptor in rat osteosarcoma cells. Pan LC; Price PA J Biol Chem; 1987 Apr; 262(10):4670-5. PubMed ID: 3031030 [TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo. Reinhardt TA; Horst RL Endocrinology; 1990 Aug; 127(2):942-8. PubMed ID: 2164926 [TBL] [Abstract][Full Text] [Related]
13. The effects of sodium butyrate on the retinoic acid-induced changes in 1,25-dihydroxyvitamin D3 receptors in tumorigenic and nontumorigenic bone derived cell lines. Lee KL; Petkovich PM; Heersche JN Endocrinology; 1988 Jun; 122(6):2399-406. PubMed ID: 2836162 [TBL] [Abstract][Full Text] [Related]
14. Affinity of 22-oxa-1,25(OH)2D3 for 1,25-dihydroxyvitamin D receptor and its effects on the synthesis of osteocalcin in human osteosarcoma cells. Valaja T; Mahonen A; Pirskanen A; Mäenpää PH Biochem Biophys Res Commun; 1990 Jun; 169(2):629-35. PubMed ID: 2162670 [TBL] [Abstract][Full Text] [Related]
15. Activation of the 1,25-dihydroxyvitamin D3 receptor in cultured rat osteogenic sarcoma cells. Werntz DA; Catherwood BD; Deftos LJ; Manolagas SC J Recept Res; 1985; 5(2-3):147-54. PubMed ID: 2993603 [TBL] [Abstract][Full Text] [Related]
16. Regulation of 1,25-dihydroxyvitamin D3 receptors by vitamin D analogs in cultured mammalian cells. Costa EM; Hirst MA; Feldman D Endocrinology; 1985 Nov; 117(5):2203-10. PubMed ID: 2995009 [TBL] [Abstract][Full Text] [Related]
17. Modulation by epidermal growth factor of the basal 1,25(OH)2D3 receptor level and the heterologous up-regulation of the 1,25(OH)2D3 receptor in clonal osteoblast-like cells. van Leeuwen JP; Pols HA; Schilte JP; Visser TJ; Birkenhäger JC Calcif Tissue Int; 1991 Jul; 49(1):35-42. PubMed ID: 1654178 [TBL] [Abstract][Full Text] [Related]
18. The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells. Pernalete N; Mori T; Nishii Y; Slatopolsky E; Brown AJ Endocrinology; 1991 Aug; 129(2):778-84. PubMed ID: 1649745 [TBL] [Abstract][Full Text] [Related]
19. Association between the expression of the c-myc oncogene mRNA and the expression of the receptor protein for 1,25-dihydroxyvitamin D3. Manolagas SC; Provvedini DM; Murray EJ; Murray SS; Tsonis PA; Spandidos DA Proc Natl Acad Sci U S A; 1987 Feb; 84(3):856-60. PubMed ID: 3027709 [TBL] [Abstract][Full Text] [Related]
20. Characterization of 3-epi-1alpha,25-dihydroxyvitamin D3 involved in 1alpha,25-dihydroxyvitamin D3 metabolic pathway in cultured cell lines. Masuda S; Kamao M; Schroeder NJ; Makin HL; Jones G; Kremer R; Rhim J; Okano T Biol Pharm Bull; 2000 Feb; 23(2):133-9. PubMed ID: 10706373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]